Found: 29
Select item for more details and to access through your institution.
Long-term efficacy of imatinib for treatment of metastatic GIST.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2013, v. 72, n. 2, p. 277, doi. 10.1007/s00280-013-2135-8
- By:
- Publication type:
- Article
CYP2D6 polymorphisms influence tamoxifen treatment outcomes in breast cancer patients: a meta-analysis.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2013, v. 72, n. 2, p. 287, doi. 10.1007/s00280-013-2195-9
- By:
- Publication type:
- Article
Association between GSTP1 Ile105Val polymorphism and oxaliplatin-induced neuropathy: a systematic review and meta-analysis.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2013, v. 72, n. 2, p. 305, doi. 10.1007/s00280-013-2194-x
- By:
- Publication type:
- Article
Polymorphisms in ERCC1 C8092A predict progression-free survival in metastatic/recurrent nasopharyngeal carcinoma treated with cisplatin-based chemotherapy.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2013, v. 72, n. 2, p. 315, doi. 10.1007/s00280-013-2196-8
- By:
- Publication type:
- Article
Multicenter phase II study of capecitabine combined with nedaplatin for recurrent and metastatic nasopharyngeal carcinoma patients after failure of cisplatin-based chemotherapy.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2013, v. 72, n. 2, p. 323, doi. 10.1007/s00280-013-2203-0
- By:
- Publication type:
- Article
Synergistic interactions between camptothecin and EGFR or RAC1 inhibitors and between imatinib and Notch signaling or RAC1 inhibitors in glioblastoma cell lines.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2013, v. 72, n. 2, p. 329, doi. 10.1007/s00280-013-2197-7
- By:
- Publication type:
- Article
Significant increase in hEGF uptake is correlated with formation of EGFR dimers induced by the EGFR tyrosine kinase inhibitor gefitinib.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2013, v. 72, n. 2, p. 341, doi. 10.1007/s00280-013-2198-6
- By:
- Publication type:
- Article
The pharmacokinetics of letrozole in brain and brain tumor in rats with orthotopically implanted C6 glioma, assessed using intracerebral microdialysis.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2013, v. 72, n. 2, p. 349, doi. 10.1007/s00280-013-2205-y
- By:
- Publication type:
- Article
Hepatic activation of irinotecan predicts tumour response in patients with colorectal liver metastases treated with DEBIRI: exploratory findings from a phase II study.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2013, v. 72, n. 2, p. 359, doi. 10.1007/s00280-013-2199-5
- By:
- Publication type:
- Article
Between-course targeting of methotrexate exposure using pharmacokinetically guided dosage adjustments.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2013, v. 72, n. 2, p. 369, doi. 10.1007/s00280-013-2206-x
- By:
- Publication type:
- Article
A phase I, open-label, mass balance study of [C] dacomitinib (PF-00299804) in healthy male volunteers.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2013, v. 72, n. 2, p. 379, doi. 10.1007/s00280-013-2207-9
- By:
- Publication type:
- Article
A phase I, open-label, mass balance study of [(14)C] dacomitinib (PF-00299804) in healthy male volunteers.
- Published in:
- 2013
- By:
- Publication type:
- Journal Article
Safety, tolerability, pharmacokinetics, and pharmacodynamics of a long-acting release (LAR) formulation of pasireotide (SOM230) in patients with gastroenteropancreatic neuroendocrine tumors: results from a randomized, multicenter, open-label, phase I study
- Published in:
- Cancer Chemotherapy & Pharmacology, 2013, v. 72, n. 2, p. 387, doi. 10.1007/s00280-013-2202-1
- By:
- Publication type:
- Article
Epidermal growth factor receptor ( EGFR) and KRAS mutations during chemotherapy plus anti-EGFR monoclonal antibody treatment in metastatic colorectal cancer.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2013, v. 72, n. 2, p. 397, doi. 10.1007/s00280-013-2211-0
- By:
- Publication type:
- Article
Epidermal growth factor receptor (EGFR) and KRAS mutations during chemotherapy plus anti-EGFR monoclonal antibody treatment in metastatic colorectal cancer.
- Published in:
- 2013
- By:
- Publication type:
- journal article
Death receptor 5 agonistic antibody PRO95780: preclinical pharmacokinetics and concentration-effect relationship support clinical dose and regimen selection.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2013, v. 72, n. 2, p. 405, doi. 10.1007/s00280-013-2200-3
- By:
- Publication type:
- Article
Validation of tumour models for use in anticancer nanomedicine evaluation: the EPR effect and cathepsin B-mediated drug release rate.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2013, v. 72, n. 2, p. 417, doi. 10.1007/s00280-013-2209-7
- By:
- Publication type:
- Article
Validation of tumour models for use in anticancer nanomedicine evaluation: the EPR effect and cathepsin B-mediated drug release rate.
- Published in:
- 2013
- By:
- Publication type:
- journal article
Phase II study of single agent oral vinorelbine as first-line treatment in patients with HER-2 negative metastatic breast cancer.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2013, v. 72, n. 2, p. 429, doi. 10.1007/s00280-013-2216-8
- By:
- Publication type:
- Article
A high serum level of M65 is associated with tumour aggressiveness and an unfavourable prognosis for epithelial ovarian cancer.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2013, v. 72, n. 2, p. 437, doi. 10.1007/s00280-013-2212-z
- By:
- Publication type:
- Article
Maintenance therapy with pemetrexed versus docetaxel after induction therapy with carboplatin and pemetrexed in chemotherapy-naïve patients with advanced non-squamous non-small-cell lung cancer: a randomized, phase II study.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2013, v. 72, n. 2, p. 445, doi. 10.1007/s00280-013-2218-6
- By:
- Publication type:
- Article
Maintenance therapy with pemetrexed versus docetaxel after induction therapy with carboplatin and pemetrexed in chemotherapy-naïve patients with advanced non-squamous non-small-cell lung cancer: a randomized, phase II study.
- Published in:
- 2013
- By:
- Publication type:
- Journal Article
Risk of hemoptysis in patients with resected squamous cell and other high-risk lung cancers treated with adjuvant bevacizumab.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2013, v. 72, n. 2, p. 453, doi. 10.1007/s00280-013-2219-5
- By:
- Publication type:
- Article
A multi-institutional phase II trial of hepatic arterial infusion chemotherapy with cisplatin for advanced hepatocellular carcinoma with portal vein tumor thrombosis.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2013, v. 72, n. 2, p. 463, doi. 10.1007/s00280-013-2222-x
- By:
- Publication type:
- Article
A predictive pharmacokinetic-pharmacodynamic model of tumor growth kinetics in xenograft mice after administration of anticancer agents given in combination.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2013, v. 72, n. 2, p. 471, doi. 10.1007/s00280-013-2208-8
- By:
- Publication type:
- Article
DMET™ (Drug-Metabolizing Enzymes and Transporters) microarray analysis of colorectal cancer patients with severe 5-fluorouracil-induced toxicity.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2013, v. 72, n. 2, p. 483, doi. 10.1007/s00280-013-2210-1
- By:
- Publication type:
- Article
DMET[TM] (Drug-Metabolizing Enzymes and Transporters) microarray analysis of colorectal cancer patients with severe 5-fluorouracil-induced toxicity.
- Published in:
- 2013
- By:
- Publication type:
- Journal Article
Ipilimumab-induced endocrinopathies: when to start corticosteroids (or not).
- Published in:
- 2013
- By:
- Publication type:
- Letter
Erratum to: Differential toxicity biomarkers for irinotecan- and oxaliplatin- containing chemotherapy in colorectal cancer.
- Published in:
- 2013
- By:
- Publication type:
- Correction notice